AI in clinical trials: Building better trials before they st...
With AI, trial sponsors are now reducing risk, accelerating timelines, and driving innovation by modelling what is most likely to work in the future.
Newsletters and Deep Dive digital magazine
With AI, trial sponsors are now reducing risk, accelerating timelines, and driving innovation by modelling what is most likely to work in the future.
How can pharma lead the way in ethical AI and trust-driven innovation?
As investors place increasing emphasis on operational maturity alongside scientific excellence, cyber resilience must become part of the conversation.
Unfortunately, much of the discussion around the JCA has focused on how the framework is intended to operate, rather than how it works in practice.
At an event in New York City, EVERSANA shared updates, customer perspectives, and future plans for its AI agency, which is moving beyond that mandate.
Editor's Picks
Newsletters and Deep Dive
digital magazine